Skip to content

Drug interactions

Rasagiline + Teriflunomide

Severity: Minor

Rasagiline and Teriflunomide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Teriflunomide is a weak inducer of CYP1A2 and may modestly lower exposure to CYP1A2 substrates such as rasagiline. Reduced rasagiline levels could diminish its antiparkinsonian effect. The effect is generally small.

What this interaction means in plain words

Rasagiline and Teriflunomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Rasagiline belongs to Central Nervous System; Teriflunomide belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Teriflunomide weakly induces CYP1A2, increasing the metabolism of rasagiline.

What to do

Monitor motor symptom control after teriflunomide is started. Increase rasagiline within the labeled dose range only if efficacy is clearly lost.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rasagiline and Teriflunomide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rasagiline with Teriflunomide?

MediHelp rates the interaction as minor. Rasagiline and Teriflunomide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Teriflunomide is a weak inducer of CYP1A2 and may modestly lower exposure to CYP1A2 substrates such as rasagiline. Reduced rasagiline levels could diminish its antiparkinsonian effect. The effect is generally small.

How serious is the interaction between Rasagiline and Teriflunomide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor motor symptom control after teriflunomide is started. Increase rasagiline within the labeled dose range only if efficacy is clearly lost.

What other medicines interact with Rasagiline?

MediHelp also lists interactions of Rasagiline with, for example, Atomoxetine, Brimonidine, Bupropion-naltrexone. The full list is on the Rasagiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in